[Wagg & Purr] Atipamezole Injection

Pays: Australie

Langue: anglais

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingrédients actifs:

ATIPAMEZOLE HYDROCHLORIDE

Disponible depuis:

AVET HEALTH LIMITED

DCI (Dénomination commune internationale):

atipamezole HCl(5mg/mL)

forme pharmaceutique:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

ATIPAMEZOLE HYDROCHLORIDE UNGROUPED Active 5.0 mg/ml

Unités en paquet:

10mL

classe:

VM - Veterinary Medicine

Fabriqué par:

MODERN VET THERAPEUT

Groupe thérapeutique:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Domaine thérapeutique:

ANTIDOTES

indications thérapeutiques:

MEDETOMIDINE REVERSING AGENT&ANTAGONIST

Descriptif du produit:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; DOG: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; DOG: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; For parenteral use in reversing and abolishing the effects of medetomidine hydrochloride in dogs and cats.Use in pregnant animals has not been established, and is therefore not recommended.

Statut de autorisation:

Registered

Date de l'autorisation:

2023-07-01

Notice patient

Product Name:
Application No:
[Wagg & Purr] Atipamazole Injection
63527/129270
Label Name:
[Wagg & Purr] Atipamazole Injection
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
5 mg/m
L
ATIPAMEZOLE HYDROCHLORIDE
Claims:
[Short Claim]
Specific
reverser of medetomidine for dogs and cats.
[Long Claim]
For parenteral use in reversing and abolishing the effects of
medetomidine
hydrochloride in dogs and cats.
Net Contents:
10mL
Directions for Use:
Restraints:
Contraindications:
The use of [Wagg & Purr] Atipamezole Injection in pregnant animals has
not been
established and is therefore not recommended.
Precautions:
Due to the potent pharmacological activity of [Wagg & Purr]
Atipamezole Injection, skin
contact with atipamezole solution should be avoided. Wipe any spillage
off the skin of the
animal.
Side Effects:
In dogs, a transient hypotensive effect has been observed during the
first 10 minutes post-
injection. Vomiting and panting after [Wagg & Purr] Atipamezole
Injection have been
reported but these effects appear to be rare. Transient over-alertness
and tachycardia
may be observed after a possible overdose. RLP APPROVED
Dosage and
Administration:
Discard unused product within 6 months of first broaching the vial.
For intramuscular injection.
Species Dose Quantity
Dog I.M./ 5 x medetomidine dose (50-400 µg/kg) Same volume as the
medetomidine
dose Cat I.M./ 2.5 x medetomidine dose (125-375 µg/kg) Half the
volume of the
medetomidine dose
[Wagg & Purr] Atipamezole Injection is absorbed quickly and is
generally administered
15-60 minutes after medetomidine.
General Directions:
Description
A clear colourless solution for injection.
Indications
[Wagg & Purr] Atipamezole Injection
is a selective alpha -2 adrenergic receptor
antagonist which is capable of reversing and abolishing the effects of
medetomidine
hydrochloride in dogs and cats.
Withholding Periods:
Trade Advice:
Safety Directions:
First Aid Instructions:
If poisoning occurs, contact a doc